ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY

ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY was reported 54 times

ALLOGENIC BONE MARROW TRANSPLANTATION THERAPY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD33-directed Immunoconjugate [EPC] 2 0.0005
1 Cannabinoid [EPC] 1 0.0001
2 CD30-directed Immunoconjugate [EPC] 1 0.0001
3 Penem Antibacterial [EPC] 3 0.0001
4 Lipid-based Polyene Antifungal [EPC] 1 0.0001
5 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1 0.0001
6 Complement Inhibitor [EPC] 4 0.0001
7 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
8 BCL-2 Inhibitor [EPC] 4 0.0001
9 Topoisomerase Inhibitor [EPC] 4 0.0001
10 Calcineurin Inhibitor Immunosuppressant [EPC] 6 0.0000
11 Bile Acid [EPC] 1 0.0000
12 Iron Chelator [EPC] 1 0.0000
13 Oxazolidinone Antibacterial [EPC] 1 0.0000
14 Nucleoside Metabolic Inhibitor [EPC] 9 0.0000
15 Alkylating Drug [EPC] 8 0.0000
16 Glycopeptide Antibacterial [EPC] 2 0.0000
17 Azole Antifungal [EPC] 4 0.0000
18 Polyene Antifungal [EPC] 1 0.0000
19 Folate Analog Metabolic Inhibitor [EPC] 9 0.0000
20 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
21 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
22 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
23 Leukocyte Growth Factor [EPC] 2 0.0000
24 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
25 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
26 Aromatase Inhibitor [EPC] 1 0.0000
27 Fluoroquinolone Antibacterial [EPC] 1 0.0000
28 Corticosteroid [EPC] 7 0.0000
29 Opioid Agonist [EPC] 1 0.0000
30 Platinum-based Drug [EPC] 1 0.0000
31 Vitamin D [EPC] 1 0.0000
32 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
33 Vitamin B12 [EPC] 1 0.0000
34 Vitamin C [EPC] 1 0.0000
35 Insulin Analog [EPC] 1 0.0000
36 Proton Pump Inhibitor [EPC] 1 0.0000
37 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000